Effects of Ipilimumab on expanded tumor infiltrating lymphocytes in patients with stage IV malignant melanoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Effects of Ipilimumab on expanded tumor infiltrating lymphocytes in patients with stage IV malignant melanoma ; volume:1 ; number:1 ; day:7 ; month:11 ; year:2013 ; pages:1 ; date:11.2013
Journal for ImmunoTherapy of Cancer ; 1, Heft 1 (7.11.2013), 1, 11.2013
- Creator
-
Bjørn, Jon
- Contributor
-
Donia, Marco V.
Andersen, Rikke
Hadrup, Sine R.
Svane, Inge Marie
SpringerLink (Online service)
- DOI
-
10.1186/2051-1426-1-S1-P241
- URN
-
urn:nbn:de:1111-2016072654548
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bjørn, Jon
- Donia, Marco V.
- Andersen, Rikke
- Hadrup, Sine R.
- Svane, Inge Marie
- SpringerLink (Online service)
Other Objects (12)
Tumor-infiltrating lymphocytes predict cutaneous melanoma survival
LAG3 and TIGIT Expression on Tumor-Infiltrating Lymphocytes in Cutaneous Melanoma
S76. Adoptive cell therapy of melanoma with autologous tumour infiltrating lymphocytes
Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option
Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian ipilimumab expanded access programme (EAP)
BRAF and MEK inhibition in melanoma patients enables reprogramming of tumor infiltrating lymphocytes
Tumor-Infiltrating Lymphocytes in Wilms Tumor
Multispectral imaging of formalin-fixed tissue predicts ability to generate tumor-infiltrating lymphocytes from melanoma
S47. Tumour infiltrating lymphocytes - a predictive marker?
Ipilimumab in patients with melanoma and autoimmune disease
Relevance of tumor-infiltrating lymphocytes in breast cancer
The role of tumor-infiltrating lymphocytes in cholangiocarcinoma
Tumor-infiltrating lymphocytes predict cutaneous melanoma survival
LAG3 and TIGIT Expression on Tumor-Infiltrating Lymphocytes in Cutaneous Melanoma
S76. Adoptive cell therapy of melanoma with autologous tumour infiltrating lymphocytes
Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option
Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian ipilimumab expanded access programme (EAP)
BRAF and MEK inhibition in melanoma patients enables reprogramming of tumor infiltrating lymphocytes
Tumor-Infiltrating Lymphocytes in Wilms Tumor
Multispectral imaging of formalin-fixed tissue predicts ability to generate tumor-infiltrating lymphocytes from melanoma
S47. Tumour infiltrating lymphocytes - a predictive marker?
Ipilimumab in patients with melanoma and autoimmune disease
Relevance of tumor-infiltrating lymphocytes in breast cancer
The role of tumor-infiltrating lymphocytes in cholangiocarcinoma
Tumor-infiltrating lymphocytes predict cutaneous melanoma survival
LAG3 and TIGIT Expression on Tumor-Infiltrating Lymphocytes in Cutaneous Melanoma
S76. Adoptive cell therapy of melanoma with autologous tumour infiltrating lymphocytes
Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option
Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian ipilimumab expanded access programme (EAP)
BRAF and MEK inhibition in melanoma patients enables reprogramming of tumor infiltrating lymphocytes
Tumor-Infiltrating Lymphocytes in Wilms Tumor
Multispectral imaging of formalin-fixed tissue predicts ability to generate tumor-infiltrating lymphocytes from melanoma
S47. Tumour infiltrating lymphocytes - a predictive marker?
Ipilimumab in patients with melanoma and autoimmune disease
Relevance of tumor-infiltrating lymphocytes in breast cancer